Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Prostate|January 21, 2006
Tumor-related immunity in prostate cancer patients treated with human recombinant granulocyte monocyte-colony stimulating factor (GM-CSF)Thomas Schwaab, Christopher P G Tretter, Jennifer J Gibson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Implications of LINE1 methylation for bladder cancer risk in womenCharlotte S Wilhelm, Karl T Kelsey, Rondi Butler, et al.
Cancer|October 15, 2013
Body mass and smoking are modifiable risk factors for recurrent bladder cancerAsaf Wyszynski, Sam A Tanyos, Judy R Rees, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 28, 2012
Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samplesDana van Bemmel, Petra Lenz, Linda M Liao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 5, 2012
Cell-cycle control in urothelial carcinoma: large-scale tissue array analysis of tumor tissue from Maine and VermontPetra Lenz, Ruth Pfeiffer, Dalsu Baris, et al.
Plos One|September 3, 2010
Identification of methylated genes associated with aggressive bladder cancerCarmen J Marsit, E Andres Houseman, Brock C Christensen, et al.
The Journal of Urology|February 10, 2004
Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinomaThomas Schwaab, Christopher P Tretter, Jennifer J Gibson, et al.
BJU International|March 27, 2014
Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic studyAngeline S Andrew, Jiang Gui, Ting Hu, et al.
Plos One|January 4, 2013
HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancerAngeline S Andrew, Ting Hu, Jian Gu, et al.
Journal of the National Cancer Institute|December 26, 2012
Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancerIndu Kohaar, Patricia Porter-Gill, Petra Lenz, et al.
Pageof 6